Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018, Published online: 24 April 2019; doi:10.1038/s41585-019-0184-4In this Consensus Statement, experts in the field detail the current evidence regarding blue light flexible cystoscopy for bladder cancer surveillance and make recommendations regarding its use on the basis of conclusions arrived at during the panel discussions at a consensus meeting.

Source: Nature Reviews Urology - April 23, 2019 Category: Urology & Nephrology Authors: Yair Lotan Trinity J. Bivalacqua Tracy Downs William Huang Jeffrey Jones Ashish M. Kamat Badrinath Konety Per-Uno Malmstr öm James McKiernan Michael O ’Donnell Sanjay Patel Kamal Pohar Matthew Resnick Alexander Sankin Angela Smith Gary Steinberg Edouar Source Type: research